Jared H. Rowe, Ph.D. - Publications

Affiliations: 
2012 Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Immunology, Microbiology Biology, Cell Biology

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rowe JH, Elia I, Shahid O, Gaudiano EF, Sifnugel NE, Johnson S, Reynolds AG, Fung ME, Joshi S, LaFleur MW, Park JS, Pauken KE, Rabinowitz JD, Freeman GJ, Haigis MC, et al. Formate supplementation enhances anti-tumor CD8+ T cell fitness and efficacy of PD-1 blockade. Cancer Discovery. PMID 37728660 DOI: 10.1158/2159-8290.CD-22-1301  0.432
2022 Sengupta S, Das S, Crespo AC, Cornel AM, Patel AG, Mahadevan NR, Campisi M, Ali AK, Sharma B, Rowe JH, Huang H, Debruyne DN, Cerda ED, Krajewska M, Dries R, et al. Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes. Nature Cancer. PMID 36138189 DOI: 10.1038/s43018-022-00427-5  0.364
2022 Elia I, Rowe JH, Johnson S, Joshi S, Notarangelo G, Kurmi K, Weiss S, Freeman GJ, Sharpe AH, Haigis MC. Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8 T cells. Cell Metabolism. PMID 35820416 DOI: 10.1016/j.cmet.2022.06.008  0.442
2019 Verheijen J, Wong SY, Rowe JH, Raymond K, Stoddard J, Delmonte OM, Bosticardo M, Dobbs K, Niemela J, Calzoni E, Pai SY, Choi U, Yamazaki Y, Comeau AM, Janssen E, et al. Defining a new immune deficiency syndrome: MAN2B2-CDG. The Journal of Allergy and Clinical Immunology. PMID 31775018 DOI: 10.1016/J.Jaci.2019.11.016  0.326
2019 Daley SR, Koay HF, Dobbs K, Bosticardo M, Wirasinha RC, Pala F, Castagnoli R, Rowe JH, Ott de Bruin LM, Keles S, Lee YN, Somech R, Holland SM, Delmonte OM, Draper D, et al. Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices. The Journal of Allergy and Clinical Immunology. PMID 31053347 DOI: 10.1016/J.Jaci.2019.03.022  0.464
2018 Ott de Bruin LM, Bosticardo M, Barbieri A, Lin SG, Rowe JH, Poliani PL, Ching K, Eriksson D, Landegren N, Kämpe O, Manis JP, Notarangelo LD. Hypomorphic Rag1 mutations alter the pre-immune repertoire at early stages of lymphoid development. Blood. PMID 29743177 DOI: 10.1182/Blood-2017-12-820985  0.443
2018 Rowe JH, Delmonte OM, Keles S, Stadinski BD, Dobbs AK, Henderson LA, Yamazaki Y, Allende LM, Bonilla FA, Gonzalez-Granado LI, Celikbilek Celik S, Guner SN, Kapakli H, Yee C, Pai SY, et al. Patients with mutations reveal a role for human CD3γ in T diversity and suppressive function. Blood. PMID 29653965 DOI: 10.1182/Blood-2018-02-835561  0.617
2017 Rowe JH, Stadinski BD, Henderson LA, de Bruin LO, Delmonte O, Lee YN, Teresa de la Morena M, Goyal RK, Hayward A, Chiung-Hui H, Kanariou M, King A, Kuijpers TW, Soh JY, Neven B, et al. Abnormalities of T cell receptor repertoire in CD4(+) regulatory and conventional T cells in patients with RAG mutations: implications for autoimmunity. The Journal of Allergy and Clinical Immunology. PMID 28864286 DOI: 10.1016/J.Jaci.2017.08.001  0.587
2016 Brauer PM, Pessach IM, Clarke E, Rowe JH, Ott de Bruin L, Lee YN, Dominguez-Brauer C, Comeau AM, Awong G, Felgentreff K, Zhang YH, Bredemeyer A, Al-Herz W, Du L, Ververs F, et al. Modeling altered T-cell development with human induced pluripotent stem cells from patients with RAG1 mutations and distinct immunological phenotypes. Blood. PMID 27301863 DOI: 10.1182/Blood-2015-10-676304  0.552
2014 Xin L, Jiang TT, Chaturvedi V, Kinder JM, Ertelt JM, Rowe JH, Steinbrecher KA, Way SS. Commensal microbes drive intestinal inflammation by IL-17-producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2. Proceedings of the National Academy of Sciences of the United States of America. 111: 10672-7. PMID 25002484 DOI: 10.1073/Pnas.1402336111  0.74
2014 Xin L, Ertelt JM, Rowe JH, Jiang TT, Kinder JM, Chaturvedi V, Elahi S, Way SS. Cutting edge: committed Th1 CD4+ T cell differentiation blocks pregnancy-induced Foxp3 expression with antigen-specific fetal loss. Journal of Immunology (Baltimore, Md. : 1950). 192: 2970-4. PMID 24591368 DOI: 10.4049/Jimmunol.1302678  0.746
2013 Rowe JH, Ertelt JM, Xin L, Way SS. Regulatory T cells and the immune pathogenesis of prenatal infection. Reproduction (Cambridge, England). 146: R191-203. PMID 23929902 DOI: 10.1530/Rep-13-0262  0.725
2013 Ertelt JM, Buyukbasaran EZ, Jiang TT, Rowe JH, Xin L, Way SS. B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells. Journal of Leukocyte Biology. 94: 367-76. PMID 23744647 DOI: 10.1189/Jlb.0313118  0.741
2012 Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature. 490: 102-6. PMID 23023128 DOI: 10.1038/Nature11462  0.721
2012 Rowe JH, Ertelt JM, Xin L, Way SS. Listeria monocytogenes cytoplasmic entry induces fetal wastage by disrupting maternal Foxp3+ regulatory T cell-sustained fetal tolerance. Plos Pathogens. 8: e1002873. PMID 22916020 DOI: 10.1371/Journal.Ppat.1002873  0.734
2012 Rowe JH, Ertelt JM, Way SS. Innate IFN-γ is essential for programmed death ligand-1-mediated T cell stimulation following Listeria monocytogenes infection. Journal of Immunology (Baltimore, Md. : 1950). 189: 876-84. PMID 22711893 DOI: 10.4049/Jimmunol.1103227  0.778
2012 Rowe JH, Ertelt JM, Way SS. Foxp3(+) regulatory T cells, immune stimulation and host defence against infection. Immunology. 136: 1-10. PMID 22211994 DOI: 10.1111/J.1365-2567.2011.03551.X  0.772
2012 Aguilera M, Rowe J, Ertelt J, Ramin K, Way SS. 139: Foxp3+ regulatory T cells sustain pregnancy through a CTLA-4 independent pathway American Journal of Obstetrics and Gynecology. 206: S74. DOI: 10.1016/J.Ajog.2011.10.157  0.705
2011 Ertelt JM, Johanns TM, Mysz MA, Nanton MR, Rowe JH, Aguilera MN, Way SS. Selective culling of high avidity antigen-specific CD4+ T cells after virulent Salmonella infection. Immunology. 134: 487-97. PMID 22044420 DOI: 10.1111/J.1365-2567.2011.03510.X  0.831
2011 Ertelt JM, Rowe JH, Mysz MA, Singh C, Roychowdhury M, Aguilera MN, Way SS. Foxp3+ regulatory T cells impede the priming of protective CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 2569-77. PMID 21810602 DOI: 10.4049/Jimmunol.1100374  0.809
2011 Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS. Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host & Microbe. 10: 54-64. PMID 21767812 DOI: 10.1016/J.Chom.2011.06.005  0.728
2011 Johanns TM, Law CY, Kalekar LA, O'Donnell H, Ertelt JM, Rowe JH, Way SS. Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection. Microbes and Infection / Institut Pasteur. 13: 322-30. PMID 21134485 DOI: 10.1016/J.Micinf.2010.11.004  0.766
2010 Johanns TM, Ertelt JM, Rowe JH, Way SS. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. Plos Pathogens. 6: e1001043. PMID 20714351 DOI: 10.1371/Journal.Ppat.1001043  0.81
2010 Ertelt JM, Johanns TM, Rowe JH, Way SS. Interleukin (IL)-21-independent pathogen-specific CD8+ T-cell expansion, and IL-21-dependent suppression of CD4+ T-cell IL-17 production. Immunology. 131: 183-91. PMID 20465570 DOI: 10.1111/J.1365-2567.2010.03287.X  0.766
2010 Johanns TM, Ertelt JM, Lai JC, Rowe JH, Avant RA, Way SS. Naturally occurring altered peptide ligands control Salmonella-specific CD4+ T cell proliferation, IFN-gamma production, and protective potency. Journal of Immunology (Baltimore, Md. : 1950). 184: 869-76. PMID 20026741 DOI: 10.4049/Jimmunol.0901804  0.806
2009 Ertelt JM, Rowe JH, Johanns TM, Lai JC, McLachlan JB, Way SS. Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 3032-8. PMID 19234199 DOI: 10.4049/Jimmunol.0803402  0.821
2009 Rowe JH, Johanns TM, Ertelt JM, Lai JC, Way SS. Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge. Immunology. 128: e471-8. PMID 19191906 DOI: 10.1111/J.1365-2567.2008.03001.X  0.831
2008 Rowe JH, Johanns TM, Ertelt JM, Way SS. PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes. Journal of Immunology (Baltimore, Md. : 1950). 180: 7553-7. PMID 18490756 DOI: 10.4049/Jimmunol.180.11.7553  0.818
Show low-probability matches.